Back to Search Start Over

Preparation and In Vivo Evaluation of Rosmarinic Acid-Loaded Transethosomes After Percutaneous Application on a Psoriasis Animal Model.

Authors :
Rodríguez-Luna, Azahara
Talero, Elena
Ávila-Román, Javier
Romero, Ana María Fernández
Rabasco, Antonio M.
Motilva, Virginia
González-Rodríguez, María Luisa
Source :
AAPS PharmSciTech; Apr2021, Vol. 22 Issue 3, p1-18, 18p
Publication Year :
2021

Abstract

The topical use of rosmarinic acid (RA) in skin inflammatory pathologies is restricted due to its poor water solubility, poor permeability, and chemical instability. In this study, RA-loaded transethosomes-in-Carbopol<superscript>®</superscript> formulations have been developed to evaluate its anti-inflammatory activity on imiquimod-induced psoriasis-like skin inflammation in mice. In vitro release profiles demonstrated sustained behavior due to the retentive action of gel and the entrapment of RA into the vesicles. However, the low viscosity of the combined formulation increased the drug release rate. Animal evaluation of anti-inflammatory activity demonstrated that transethosomes-in-gel containing dexamethasone (Dex-TE-Gel), as positive control, showed effect in all the pro-inflammatory parameters evaluated, evidencing that these drug-loaded nanocarriers have been effectively reached the site of action. In addition, transethosomes-in-gel containing RA (RA-TE-Gel) formulations produced a great reduction in the punch edema (P < 0.001) and in TNF-α and IL-6 (P < 0.05). However, non-significant differences were obtained for IL-1β, IL17, and MPO. Despite the protecting effect of Carbopol<superscript>®</superscript> and transethosomes on oxidation index and antioxidant activity of RA over the 7 days of treatment, however, a degradation process of this antioxidant to caffeic acid may be the cause of these in vivo results. We have also checked that the pH existing into the intercellular space of damaged cells (pH 6.8) may be affecting. Therefore, our results suggest that RA-TE-Gel could act as an effective RA formulation for skin delivery; further studies will help to understand the loss of activity at the cellular level. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15309932
Volume :
22
Issue :
3
Database :
Complementary Index
Journal :
AAPS PharmSciTech
Publication Type :
Academic Journal
Accession number :
149631465
Full Text :
https://doi.org/10.1208/s12249-021-01966-3